Description
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Product Unit Size | Cost | Quantity | Stock |
---|
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Cas No. | 9002-10-2 |
---|---|
Purity | ≥95% |
Formula | C42H66N10O16S2 |
Formula Wt. | 1031.2 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Guillaume B, Stroobant V, Bousquet-Dubouch MP, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol. 2012 Oct 1;189(7):3538-47. PMID: 22925930.
Mitchell MS, Darrah D, Yeung D, et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15;20(4):1075-86. PMID: 11844833.
Furocoumarin; voltage-gated Na+ channel blocker...
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
p38 MAPK inhibitor.
Impurity of diclofenac
Rifamycin derivative, induces pore formation in...
Neurotoxin, mutagen.
Melanoma-associated antigen.
Purine nucleoside analog; DNA chain terminator....
Cyclic hexadepsipeptide mycotoxin produced by C...
Peptide, carbonic anhydrase G250 epitope.
Inhibitor of EGFR.
pan-PI3K inhibitor
Ellagic acid derivative produced by gut microfl...
Triterpene saponin found in species of Panax.
ROCK inhibitor.
Pim-1 inhibitor.
β-lactam; penicillin binding protein inhibitor...
PKC activator, carcinogen.
Podophyllotoxin derivative found in Podophyllum...
PDE4 inhibitor.